Charlotte M McKee MD
Critical Care Medicine, Cystic Fibrosis
Chief Medical Officer, Sionna Therapeutics
Join to View Full Profile
22 Strathmore RdNatick, MA 01760
Dr. McKee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1998- Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994
Columbia University Vagelos College of Physicians and SurgeonsClass of 1991
Columbia UniversityMA, History, 1988 - 1989- Harvard UniversityBA, History of Science, Magna Cum Laude, 1982 - 1986
Publications & Presentations
PubMed
- 722 citationsEfficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double...Harry G.M. Heijerman, Edward F. McKone, Damian G. Downey, Eva Van Braeckel, Steven M. Rowe
Lancet. 2019-11-23 - 1146 citationsElexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del AllelePeter G. Middleton, Marcus A. Mall, Pavel Dřevínek, Larry C. Lands, Edward F. McKone
The New England Journal of Medicine. 2019-10-31 - 77 citationsClinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles.Jennifer L. Taylor-Cousar, Marcus A. Mall, Bonnie W. Ramsey, Edward F. McKone, Elizabeth Tullis
ERJ Open Research. 2019-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
